Facial Aesthetics Market Research, 2031
The global facial aesthetics market size was valued at $6.23 billion in 2021, and is projected to reach $25.76 billion by 2031, growing at a CAGR of 15.5% from 2022 to 2031. Facial aesthetics is a non-invasive aesthetic procedure performed to treat skin conditions such as scars, acne, hyperpigmentation, wrinkles, dark skin, and stretch marks. There are different facial aesthetic procedures such as cosmetic implants, chemical peels, dermal fillers, botulinum toxin and microdermabrasion, which are used to improve aesthetic appearance. Dermal fillers such as hyaluronic acid (HA), calcium hydroxylapatite (CaHA), poly-L-lactic acid, and polymethyl-methacrylate microspheres (PMMA) are used in facial aesthetic procedures.
Growth of the global facial aesthetics market size is majorly driven by increase in number of facial aesthetic procedure, rise in female population, increase in number of key players to offer different facial aesthetic products and rise in number of product approvals by different key players. For instance, in May 2020, Galderma, a dermatology and pharmaceutical company, announced the U.S Food & Drug Administration (FDA) approval for restylane kysse, which is a new hyaluronic acid filler specifically designed and indicated to add fullness to lips and help smoothen wrinkles above the mouth. Moreover, in February 2022, Merz Aesthetics, a medical aesthetics company, announced the launch of Radiesse (+) Lidocaine injectable implant for deep injection to improve moderate to severe loss of jawline contour in adults over the age of 21.
In addition, technological advancement in medical aesthetic products propels the market growth. For instance, In March 2021, Solta Medical Business, a global leader in medical aesthetic market, announced the launch of Clear + Brilliant Touch laser, which is leaser skin treatment device for patients of all ages and skin type. It is fractional laser technology to create structural and functional changes to the skin, helping to prevent the early signs of aging, maintain youthful looking skin and improve the skin's overall appearance.
Moreover, increase in self-awareness among young population regarding physical appearance propels the demand for facial aesthetics treatment. In addition, increase in sedentary lifestyle in young population, further led to appearance issues such as facial hair and pigmentation, making them conscious about their appearance, which increases the need for facial aesthetic procedure. For instance, Botulinum toxin aims to reduce facial fine lines and wrinkles, and encourages young population to go for such kind of facial aesthetic procedure. Moreover, facial aesthetics are used in a wide range of applications such as lip enhancement, restoration of facial volume and face rejuvenation. In addition, full field ablative, photo rejuvenation and micro-ablative resurfacing are the procedures used to perform skin lightning, improving skin texture and treating facial lines.
However, high costs associated with facial aesthetic procedure are anticipated to limit its adoption during the facial aesthetics market forecast period. For instance, according to the American Society of plastic surgeons, the average cost of botulinum toxin injection is $446 and along with injection, the patient needs to pay additional fees of surgeon who performs botulinum procedure. Thus, this factor is anticipated to hinder the facial aesthetics market growth.
Global Facial Aesthetics Market Segmentation
The facial aesthetics market is segmented into product, application and end user, and region. The product segment is further classified into dermal fillers, botulinum toxin, microdermabrasion, chemical peels and others. The others include full field ablative, photo rejuvenation, micro-ablative resurfacing. On the basis of application, the market is segmented into facial line correction treatment, scar treatment, lip enhancement, restoration of volume/ fullness and others. The others include age spots, wrinkle caused by sun damage or aging, skin lifting and skin smoothening. On the basis of end user, the market is segmented into specialty & dermatology clinics, hospitals and others. The others include beauty salon, aesthetic clinic, and an office facility.
Region-wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and the rest of Europe), Asia-Pacific (Japan, China, Australia, India and the rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, Colombia, and the rest of LAMEA).
Product Segment Review
On the basis of product, the market is classified into dermal fillers, botulinum toxin, microdermabrasion, chemical peels and others. The dermal fillers segment dominated the market in 2021, and is expected to continue this trend during the forecast period, owing to increase in adoption of dermal fillers among young female population and rise in awareness about effectiveness of hyaluronic acid procedure.
On the other hand, the botulinum toxin segment is expected to witness considerable market growth during the forecast period, owing to increase in R&D initiatives for development of advanced botulinum toxin product and growth in demand for therapeutic and aesthetic indication of botulinum toxin.
Application Segment Review
On the basis of application, it is classified into facial line correction treatment, scar treatment, lip enhancement, restoration of volume/ fullness and others. The facial line correction treatment segment dominated the market in 2021, and is expected to continue this trend during the forecast period, owing to increase in geriatric population who develop facial line and rise in demand for facial line correction treatment procedure.
End User Segment Review
On the basis of end user, the market is classified into specialty & dermatology clinics, hospitals and others. The hospital segment dominated the market in 2021, and is expected to continue this trend during the forecast period, owing to increase in number of hospitals to conduct facial aesthetic procedure, and rise in expenditure by governments to improve the aesthetic center in hospital.
However, the specialty & dermatology clinics segment is expected to witness considerable growth during the forecast period, owing to rise in prevalence of skin condition such as hyperpigmentation, acne, scars, stretch marks and increase in number of professionals who provide treatment of facial aesthetics in dermatology clinics.
Regional Segment Review
Region wise, North America accounted for a majority of the facial aesthetics market share in 2021, and is anticipated to remain dominant during the forecast period. This is attributed to rise in number of botulinum toxin procedures, increase in number of approvals for facial aesthetics products, presence of facial aesthetics industry, and advancements in medical and aesthetic sector in the region.
Asia-Pacific is anticipated to witness lucrative growth, owing to increase in number of female population, rise in awareness among young population regarding availability of different facial aesthetic procedure, growth in healthcare expenditures, and rise in adoption of facial aesthetic products.
The key players operating in the global facial aesthetics market include AbbVie, Anika Therapeutics, Inc., Bausch Health Companies Inc., Candela Syneron, Cutera, Inc., Cynosure, Elan aesthetics, Evolus Inc., Fotona D.O.O, Galderma Laboratories, Ipsen, Johnson and Johnson, Merz Pharma, Revance Therapeutics, Sinclair Pharma, Teoxane, and Vital Esthetique.
Key Benefits For Stakeholders
- This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the facial aesthetics market analysis from 2021 to 2031 to identify the prevailing facial aesthetics facial aesthetics market opportunity.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the facial aesthetics market segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes the analysis of the regional as well as global facial aesthetics market trends, key players, market segments, application areas, and market growth strategies.
Facial Aesthetics Market Report Highlights
| Aspects | Details |
 By Product |
|
 By Application |
|
 By End User |
|
 By Region |
|
 Key Market Players | Bausch Health Companies Inc., merz pharma, ipsen, Revance Therapeutics, Elan aesthetics, Anika Therapeutics, Inc., Cynosure, Abbvie Inc, Teoxane, Candela Syneron, Sinclair Pharmaceuticals Limited, Vital Esthetique, Cutera, Inc., galderma laboratories, l.p., Johnson and Johnson, Evolus Inc., Fotona D.O.O |
Analyst Review
This section provides opinions of the top-level CXOs operating in the facial aesthetic market. Facial aesthetics is a non-invasive aesthetic procedure that is performed for different indication such as skin lightening, wrinkle reduction, restoration of facial volume, scar treatment, and facial line treatment. Rise in awareness regarding effectiveness of facial aesthetic procedure among the population fuels the market growth. Moreover, increase in product launch by different key players boosts the facial aesthetic market.
In March 2021, Solta Medical Business, a global leader in medical aesthetic market, announced the launch of Clear + Brilliant Touch laser, which is a laser skin treatment device for patients of all ages and skin types. It is a fractional laser technology to create structural and functional changes to the skin, helping to prevent the early signs of aging, maintain youthful looking skin and improve the skin's overall appearance. Moreover, in January 2021, Merz Aesthetics, a medical aesthetics company with the largest dedicated medical aesthetic business in the world and Candela Corporation, a leading global medical aesthetic device company announced their collaboration to provide one of the broadest medical aesthetics portfolios across the globe.
The top companies that hold the market share in facial aesthetics market are AbbVie, Anika Therapeutics, Inc., Bausch Health Companies Inc., Candela Syneron, Cutera, Inc., Cynosure, Elan aesthetics, Evolus Inc., Fotona D.O.O, Galderma Laboratories, Ipsen, Johnson and Johnson, Merz Pharma, Revance Therapeutics, Sinclair Pharma, Teoxane, and Vital Esthetique. .
The key trends in the facial aesthetics market are increase in number of facial aesthetic procedure, rise in female population, increase in number of key players to offer different facial aesthetic products and rise in number of product approvals by different key players.
The market value of facial aesthetics Market in 2022 was $7,059.3 million
The base year for the report is 2021.
Yes, facial aesthetics companies are profiled in the report
The total market value of facial aesthetics market is $6,234.5 million in 2021.
Asia-Pacific is expected to register highest CAGR of 16.5% from 2022 to 2031, owing to increase in number of female population, rise in awareness among young population regarding availability of different facial aesthetic procedure, growth in healthcare expenditures, and rise in adoption of facial aesthetic products.
The forecast period in the report is from 2022 to 2031
Loading Table Of Content...
